MedPath

Study held to see the effect of intake of nagbala milk decoction in treatment of high blood pressure

Phase 2
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2020/11/028833
Lead Sponsor
Samkit Shah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Systolic Blood Pressure: less than 170 mm of Hg more than or equal to 140 mm of Hg.

2)Diastolic Blood Pressure: less than or equal to 110 mm of Hg or More than 90 mm of Hg.

3)Patient willing to enroll in the research & to sign the consent form

Exclusion Criteria

1)Patient who have past history of atrial fibrillation, acute coronary syndrome, myocardial infarction, stroke or right ventricular hypertrophy, left ventricular hypertrophy, severe arrhythmia in last 6 months.

2)Symptomatic patients with clinical features of early heart failure.

3)Secondary hypertension.

4)Women who are pregnant and lactating or on estrogen replacement therapy.

5)Alcoholics and drug abusers.

6)Accelerated and malignant hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
agbala kshirpaka is effective in the management of essential hypertension. <br/ ><br>Timepoint: 21 days study with 3 follow ups (0,7,14,21 days) <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath